Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4Q6P6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 48 | 52 | PF00656 | 0.350 |
CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.409 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.498 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.554 |
LIG_14-3-3_CanoR_1 | 127 | 135 | PF00244 | 0.507 |
LIG_14-3-3_CanoR_1 | 138 | 147 | PF00244 | 0.493 |
LIG_14-3-3_CanoR_1 | 23 | 31 | PF00244 | 0.516 |
LIG_14-3-3_CanoR_1 | 59 | 65 | PF00244 | 0.308 |
LIG_14-3-3_CanoR_1 | 90 | 94 | PF00244 | 0.452 |
LIG_eIF4E_1 | 129 | 135 | PF01652 | 0.514 |
LIG_eIF4E_1 | 7 | 13 | PF01652 | 0.428 |
LIG_FHA_1 | 123 | 129 | PF00498 | 0.370 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.408 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.453 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.535 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.477 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.572 |
LIG_FHA_2 | 75 | 81 | PF00498 | 0.533 |
LIG_LIR_Gen_1 | 14 | 21 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 22 | 32 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 14 | 19 | PF02991 | 0.408 |
LIG_LIR_Nem_3 | 22 | 27 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 77 | 82 | PF02991 | 0.527 |
LIG_LIR_Nem_3 | 92 | 96 | PF02991 | 0.497 |
LIG_NRBOX | 146 | 152 | PF00104 | 0.468 |
LIG_PCNA_PIPBox_1 | 1 | 10 | PF02747 | 0.498 |
LIG_SH2_SRC | 72 | 75 | PF00017 | 0.539 |
LIG_SH2_STAP1 | 129 | 133 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 16 | 19 | PF00017 | 0.432 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.334 |
LIG_UBA3_1 | 27 | 33 | PF00899 | 0.460 |
LIG_Vh1_VBS_1 | 133 | 151 | PF01044 | 0.474 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.533 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.482 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.580 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.530 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.543 |
MOD_GSK3_1 | 39 | 46 | PF00069 | 0.511 |
MOD_LATS_1 | 136 | 142 | PF00433 | 0.512 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.379 |
MOD_PIKK_1 | 32 | 38 | PF00454 | 0.394 |
MOD_PIKK_1 | 80 | 86 | PF00454 | 0.539 |
MOD_PKA_2 | 137 | 143 | PF00069 | 0.509 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.517 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.448 |
MOD_Plk_1 | 42 | 48 | PF00069 | 0.593 |
MOD_Plk_2-3 | 43 | 49 | PF00069 | 0.573 |
MOD_Plk_2-3 | 74 | 80 | PF00069 | 0.511 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.497 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.449 |
TRG_DiLeu_BaLyEn_6 | 91 | 96 | PF01217 | 0.505 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.375 |
TRG_Pf-PMV_PEXEL_1 | 94 | 99 | PF00026 | 0.463 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDH9 | Leptomonas seymouri | 59% | 100% |
A0A1X0NJ16 | Trypanosomatidae | 36% | 97% |
A0A3R7MDS1 | Trypanosoma rangeli | 42% | 96% |
A0A3S7X442 | Leishmania donovani | 89% | 100% |
A4HIZ3 | Leishmania braziliensis | 70% | 100% |
A4I6B0 | Leishmania infantum | 89% | 100% |
C9ZN37 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 99% |
E9B1G6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
V5BDZ3 | Trypanosoma cruzi | 40% | 96% |